Strides Shasun receives USFDA approval for Piroxicam capsules

Product approval from Oral dosage facility at Bangalore

Strides Shasun announced that it's wholly owned subsidiary Strides Pharma Global has received approval for Piroxicam capsules 10mg and 20mg from the United States Food & Drug Administration (US FDA). The product received approval within ten months under the GDUFA regime.

The product will be manufactured at the Company's Oral Dosage Facility at Bangalore and will be marketed by Strides Pharma Inc. in the US Market.

Powered by Capital Market - Live News